Repligen (RGEN) Non-Current Deferred Tax Liability (2011 - 2026)
Repligen's (RGEN) quarterly Non-Current Deferred Tax Liability came in at $16.8 million in Q2 2026, down 28.07% year-over-year from $23.3 million in Q2 2025, and up 11.72% quarter-over-quarter from $15.0 million in Q1 2026.
Analysis
Repligen (RGEN) Non-Current Deferred Tax Liability (2011 - 2026) Analysis & Trends
Repligen (RGEN) has reported Non-Current Deferred Tax Liability for 15 consecutive years, with $16.8 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Deferred Tax Liability fell 28.07% year-over-year to $16.8 million in Q2 2026; TTM through Jun 2026 was $16.8 million, a 28.07% decrease from a year earlier, with the FY2025 full-year figure at $22.5 million, down 1.23% from the prior year.
- Non-Current Deferred Tax Liability was $16.8 million for Q2 2026 at Repligen, up from $15.0 million in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $39.3 million in Q4 2023 and troughed at $14.5 million in Q3 2023.
- A 5-year average of $24.6 million and a median of $23.2 million in 2022 frame the typical range for Non-Current Deferred Tax Liability.
- The widest YoY moves for Non-Current Deferred Tax Liability: up 131.93% in 2024, down 42.08% in 2024.
- Over 5 years, Non-Current Deferred Tax Liability stood at $23.0 million in 2022, then surged by 70.97% to $39.3 million in 2023, then plunged by 42.08% to $22.8 million in 2024, then retreated by 1.23% to $22.5 million in 2025, then dropped by 25.42% to $16.8 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $16.8 million (Q2 2026), $15.0 million (Q1 2026), and $22.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.78 Mn |
| Mar 31, 2026 | 15.02 Mn |
| Dec 31, 2025 | 22.50 Mn |
| Sep 30, 2025 | 20.14 Mn |
| Jun 30, 2025 | 23.33 Mn |
| Mar 31, 2025 | 24.14 Mn |
| Dec 31, 2024 | 22.78 Mn |
| Sep 30, 2024 | 33.69 Mn |
| Jun 30, 2024 | 34.04 Mn |
| Mar 31, 2024 | 36.81 Mn |
| Dec 31, 2023 | 39.32 Mn |
| Sep 30, 2023 | 14.52 Mn |
| Jun 30, 2023 | 22.04 Mn |
| Mar 31, 2023 | 22.39 Mn |
| Dec 31, 2022 | 23.00 Mn |
| Sep 30, 2022 | 23.41 Mn |
| Jun 30, 2022 | 23.65 Mn |
| Mar 31, 2022 | 25.86 Mn |
| Dec 31, 2021 | 33.48 Mn |
| Sep 30, 2021 | 39.13 Mn |